Newsletter

Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

Indonesia: Guidelines for Marketing Authorization of Software-Based Medical Devices – October/November 2026

  • 2026-11-19 02:55:13

The Ministry of Health (MoH) of Indonesia has issued Minister of Health Decree No. HK.01.07/MENKES/951/2026 concerning Guidelines for Marketing Authorization of Software-Based Medical Devices, dated 7 September 2026. The decree establishes technical requirements and procedures for obtaining marketing authorization (Izin Edar) for software-based medical devices distributed in Indonesia. The new guidelines cover Software as a Medical Device (SaMD), Software in a Medical Device (SiMD), and medical devices incorporating Artificial Intelligence (AI) applications. They aim to ensure the safety, performance, and quality of software-based medical devices while addressing emerging regulatory considerations, including software lifecycle management, cybersecurity, clinical validation, and personal data protection.

More
Indonesia: Extends Halal Certification Deadlines and Revises Foreign Halal Product Regulations – October/November 2026

Indonesia: Extends Halal Certification Deadlines and Revises Foreign Halal Product Regulations – October/November 2026

  • 2026-11-19 02:33:53

The Indonesian Government has extended the phased implementation of mandatory halal certification to provide additional time for strengthening the halal ecosystem and improving the readiness of all relevant stakeholders. The deadlines have been adjusted for Class A medical device with the implementation period extending up to 17 October 2028. The Government has also amended the implementing provisions of Government Regulation No. 42 of 2024 through Government Regulation No. 40 of 2026, including changes to the provisions governing the halal conformity of foreign products entering Indonesia.

More
Japan: Voluntary Standards for Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion – October/November 2026

Japan: Voluntary Standards for Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion – October/November 2026

  • 2026-11-19 01:27:29

On November 5th, 2026, the Ministry of Health, Labour and Welfare (MHLW) announced a new Generic Name, "Home-use Nitric Oxide (NO) Generating Devices for Blood Circulation Promotion", together with a notice regarding its applicable voluntary standards. Manufacturers should refer to these documents to ensure that their devices meet the relevant definition and performance requirements. The corresponding verification reports are also expected to be included as part of the notification dossier.

More
QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

QT Activity: Webinar Recap | JAPAN & SOUTH KOREA: KEY REGULATORY DEVELOPMENTS FOR MEDICAL DEVICES – September/October 2026

  • 2026-10-27 06:15:00

Qualtech's webinar on September 17, 2026 reviewed key regulatory developments for medical devices in Japan and South Korea. The Japan session covered how existing biocompatibility reports can support PMDA submissions, including JIS T 0993-1:2020 requirements, material documentation, GLP compliance and the acceptance of overseas test data. The South Korea session outlined the Digital Medical Products Act framework, covering device status determination, classification, regulatory pathways, K-GMP and post-market obligations.

More
QT Analysis: Taiwan TFDA Upgrades IVD Regulatory Requirements for CRP and AST Systems – How Should Companies Adjust Their Market Strategy? – September/October 2026

QT Analysis: Taiwan TFDA Upgrades IVD Regulatory Requirements for CRP and AST Systems – How Should Companies Adjust Their Market Strategy? – September/October 2026

  • 2026-10-27 05:30:31

Taiwan's Food and Drug Administration (TFDA) released new guidance in August and September 2026 for C-Reactive Protein (CRP) assays and Antimicrobial Susceptibility Testing (AST) systems, two Class II in vitro diagnostic (IVD) device categories. The updates require CRM470 calibration traceability and additional clinical data for hsCRP cardiovascular risk claims, as well as multi-center accuracy studies for AST systems. This analysis reviews the key changes, their impact on registration timelines and market competition, and the value of an early technical documentation gap analysis.

More
SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

SINGAPORE: HSA INTRODUCED SUBMISSION WINDOW FOR REGISTRATION SUPPORT INITIATIVE OF UNREGISTERED MEDICAL DEVICES – September/October 2026

  • 2026-10-27 05:15:40

Singapore's Health Sciences Authority (HSA) has introduced the submission window for the inaugural year of the Registration Support Initiative for unregistered medical device previously have been accessed through Special Access Routes (SAR) to 31 December 2026. This provides medical and dental practitioners and other stakeholders with additional time to prepare submissions, engage relevant parties and obtain the necessary endorsements. From 2027 onwards, the Initiative will follow a standard annual submission cycle from 1 October to 31 December.

More
Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

Philippines: PFDA Circulates Revised Draft Regulatory Guidelines for Medical Device Software (MDSW) – September/October 2026

  • 2026-10-26 09:52:44

The Food and Drug Administration of the Philippines (PFDA) has circulated a revised draft Circular proposing updated regulatory guidelines for Medical Device Software (MDSW), including AI-enabled MDSW. The draft outlines software qualification criteria, risk-based classification, product authorization pathways, and technical documentation requirements for initial and renewal applications. It also introduces AI-specific requirements covering clinical validation, cybersecurity, risk management, and post-market monitoring. The proposed guidelines aim to strengthen the safety and performance of MDSW throughout its lifecycle. The Circular remains in draft form and is not yet effective.

More
Singapore: Healthcare Regulatory and Enforcement Functions to Move From MOH to HSA – August/September 2026

Singapore: Healthcare Regulatory and Enforcement Functions to Move From MOH to HSA – August/September 2026

  • 2026-09-21 03:51:16

Singapore will progressively consolidate healthcare regulatory functions under the Health Sciences Authority (HSA), with functions currently performed by the Ministry of Health's (MOH) Health Regulation Group and subsequently the Secretariat of healthcare Professional Boards to be transferred to HSA. The transition will take place in two phases by the end of 2026 and 2027, respectively, as part of Singapore's move towards a more integrated healthcare regulatory system.

More
Singapore: HSA Allows Concurrent Processing of Up to Two Change Notification Applications for the Same Medical Device Listing – August/September 2026

Singapore: HSA Allows Concurrent Processing of Up to Two Change Notification Applications for the Same Medical Device Listing – August/September 2026

  • 2026-09-21 03:40:18

Singapore's Health Sciences Authority (HSA) has enhanced its Change Notification (CN) process for registered medical devices. With immediate effect, up to two CN applications may now be processed concurrently for the same medical device listing, providing greater flexibility for stakeholders in managing regulatory changes and facilitating more timely implementation of device updates.

More
Philippines: An Overview of the Proposed FDA Guidelines on Good Manufacturing Practices (GMP) for Medical Devices – August/September 2026

Philippines: An Overview of the Proposed FDA Guidelines on Good Manufacturing Practices (GMP) for Medical Devices – August/September 2026

  • 2026-09-21 03:23:41

The Philippine Department of Health has released a proposed Administrative Order establishing Good Manufacturing Practice (GMP) guidelines for local medical device and IVD medical device manufacturers. The proposed Order adopts PNS ISO 13485:2019 as the Food and Drug Administration (FDA)'s official GMP guideline and applicable PNS ISO 14644 standards for clean rooms. A two-year transitory period is proposed to allow affected manufacturers to comply with the new requirements once the Order takes effect.

More